Combination Chemotherapy for Patients With Brain Cancer
Status:
Completed
Trial end date:
2001-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy using
paclitaxel and topotecan, plus G-CSF, in treating patients with glioblastoma multiforme or
anaplastic astrocytoma that is refractory or recurrent.